High Prevalence of Antiphospholipid Antibodies in Children with NonTransfusion Dependent Thalassemia and Possible Correlations with Microparticles.
作者信息
Chinsuwan Jitlada, Klaihmon Phatchanat, Kadegasem Praguywan, Chuansumrit Ampaiwan, Soisamrong Anucha, Pattanapanyasat Kovit, Wongwerawattanakoon Pakawan, Sirachainan Nongnuch
机构信息
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Center of Excellence for Flow Cytometry, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
出版信息
Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020071. doi: 10.4084/MJHID.2020.071. eCollection 2020.
Abstract
摘要
相似文献
1
High Prevalence of Antiphospholipid Antibodies in Children with NonTransfusion Dependent Thalassemia and Possible Correlations with Microparticles.
Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020071. doi: 10.4084/MJHID.2020.071. eCollection 2020.
2
Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
Acta Biomed. 2019 Sep 6;90(3):225-237. doi: 10.23750/abm.v90i3.8586.
3
Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Transfusion. 2021 Sep;61(9):2566-2577. doi: 10.1111/trf.16590. Epub 2021 Jul 14.
4
Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
Hemoglobin. 2019 Mar;43(2):95-100. doi: 10.1080/03630269.2019.1599906. Epub 2019 Jun 10.
5
Magnitude of Bone Disease in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia Patients.
Cureus. 2024 Mar 12;16(3):e56012. doi: 10.7759/cureus.56012. eCollection 2024 Mar.
6
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia.
Ann Hematol. 2024 May;103(5):1525-1539. doi: 10.1007/s00277-024-05694-z. Epub 2024 Mar 23.
7
The Prevalence of Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/β-Thalassemia Children in a Tertiary Center of West Bengal, India.
Hemoglobin. 2021 May;45(3):157-162. doi: 10.1080/03630269.2021.1933023. Epub 2021 Jun 1.
8
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide study.
Acta Biomed. 2020 Sep 7;91(3):e2020007. doi: 10.23750/abm.v91i3.10155.
9
Does thalassemia truly cause microvascular changes without us noticing? An optical coherence tomography angiography study of the children with beta-thalassemia.
Int Ophthalmol. 2023 Oct;43(10):3755-3765. doi: 10.1007/s10792-023-02786-z. Epub 2023 Jun 30.
10
PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.
Southeast Asian J Trop Med Public Health. 2016 Nov;47(6):1335-42.
本文引用的文献
1
Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction.
Sci Rep. 2018 Aug 29;8(1):13033. doi: 10.1038/s41598-018-31386-6.
2
Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation.
Ann Hematol. 2017 Oct;96(10):1741-1747. doi: 10.1007/s00277-017-3070-2. Epub 2017 Jul 26.
3
Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
Ann Hematol. 2017 Apr;96(4):597-603. doi: 10.1007/s00277-017-2925-x. Epub 2017 Feb 7.
4
Non-transfusion-dependent thalassemias.
Haematologica. 2013 Jun;98(6):833-44. doi: 10.3324/haematol.2012.066845.
5
Thiol pathways in the regulation of tissue factor prothrombotic activity.
Curr Opin Hematol. 2011 Sep;18(5):343-8. doi: 10.1097/MOH.0b013e32834981de.
6
Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients.
Int J Lab Hematol. 2008 Feb;30(1):11-6. doi: 10.1111/j.1751-553X.2007.00916.x.
7
Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
Blood Rev. 2008 Mar;22(2):93-105. doi: 10.1016/j.blre.2007.09.001. Epub 2007 Oct 25.
8
Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major.
Hematology. 2006 Aug;11(4):287-90. doi: 10.1080/10245330600954130.
9
Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.
Blood. 2004 Apr 1;103(7):2844-6. doi: 10.1182/blood-2003-09-3094. Epub 2003 Nov 26.
10
Effects of deferiprone on immune status and cytokine pattern in thalassaemia major.
Acta Haematol. 2002;108(3):144-9. doi: 10.1159/000064705.
Zotero 插件